Literature DB >> 16148439

Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods.

M P Viveros1, R Llorente, E Moreno, E M Marco.   

Abstract

The present article focuses on psychoneuroendocrine effects of cannabinoids in developing animals, with special emphasis on the perinatal, periweanling and periadolescent periods. We describe and discuss published data dealing with acute and long-term effects of exposure to cannabinoid agonists in such critical periods. Human studies have demonstrated that the consumption of marijuana by women during pregnancy affects the neurobehavioural development of their children. Investigations using animal models provide useful information for a better understanding of the long-lasting deleterious consequences of cannabis exposure during pregnancy and lactation. The increasing use of cannabis among adolescents and its associated public health problems have led to a parallel increase in basic research on appropriate animal models. Chronic administration of cannabinoid agonists during the periadolescent period causes persistent behavioural alterations in adult animals. Some of these alterations may be related to a possible increased risk of psychosis and other neuropsychiatric disorders in early onset cannabis users.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148439     DOI: 10.1097/00008877-200509000-00007

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  31 in total

Review 1.  Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?

Authors:  Rebecca M Craft; Julie A Marusich; Jenny L Wiley
Journal:  Life Sci       Date:  2012-06-20       Impact factor: 5.037

Review 2.  Neurobiological processes in adolescent addictive disorders.

Authors:  Ty S Schepis; Bryon Adinoff; Uma Rao
Journal:  Am J Addict       Date:  2008 Jan-Feb

3.  Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults.

Authors:  Krista M Lisdahl; Jenessa S Price
Journal:  J Int Neuropsychol Soc       Date:  2012-05-22       Impact factor: 2.892

Review 4.  Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history.

Authors:  Diana Dow-Edwards; Ashley Frank; Dean Wade; Jeremy Weedon; Sari Izenwasser
Journal:  Neurotoxicol Teratol       Date:  2016-09-12       Impact factor: 3.763

Review 5.  The endocannabinoid system in brain reward processes.

Authors:  M Solinas; S R Goldberg; D Piomelli
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

6.  Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study.

Authors:  Christine A Rabinak; Ashley Blanchette; Nicole L Zabik; Craig Peters; Hilary A Marusak; Allesandra Iadipaolo; Farrah Elrahal
Journal:  Psychopharmacology (Berl)       Date:  2020-03-11       Impact factor: 4.530

7.  Behavioral responses to acute and sub-chronic administration of the synthetic cannabinoid JWH-018 in adult mice prenatally exposed to corticosterone.

Authors:  Simone Macrì; Lara Lanuzza; Gustavo Merola; Chiara Ceci; Stefano Gentili; Antonella Valli; Teodora Macchia; Giovanni Laviola
Journal:  Neurotox Res       Date:  2013-01-08       Impact factor: 3.911

8.  The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex.

Authors:  T Rubino; N Realini; D Braida; T Alberio; V Capurro; D Viganò; C Guidali; M Sala; M Fasano; D Parolaro
Journal:  Neurotox Res       Date:  2009-02-28       Impact factor: 3.911

9.  The impact of adolescent social isolation on dopamine D2 and cannabinoid CB1 receptors in the adult rat prefrontal cortex.

Authors:  M L Fitzgerald; K Mackie; V M Pickel
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

10.  Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Authors:  Sagnik Bhattacharyya; Paul D Morrison; Paolo Fusar-Poli; Rocio Martin-Santos; Stefan Borgwardt; Toby Winton-Brown; Chiara Nosarti; Colin M O' Carroll; Marc Seal; Paul Allen; Mitul A Mehta; James M Stone; Nigel Tunstall; Vincent Giampietro; Shitij Kapur; Robin M Murray; Antonio W Zuardi; José A Crippa; Zerrin Atakan; Philip K McGuire
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.